OverviewSuggest Edit

Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy. It is creating a pipeline of mono-specific and bi-specific antibody therapeutics with the help of computational biology and artificial intelligence.

TypePublic
Founded2012
HQSuzhou, CN
Websiteadagene.com

Latest Updates

Employees (est.) (Dec 2020)198
Job Openings7
Revenue (FY, 2019)$480 K(-68%)
Share Price (Sept 2021)$17(+4%)
Cybersecurity ratingAMore

Key People/Management at Adagene

Man Kin Tam

Man Kin Tam

Chief Financial Officer
Felix Du

Felix Du

Chief Technology Officer
Peter Luo

Peter Luo

Chairman of the Board of Directors
Jc Xu

Jc Xu

Chief Scientific Officer
Qinghai Zhao

Qinghai Zhao

Chief Manufacturing Officer
Yan Li

Yan Li

Senior Vice President, Bioinformatics and Information Technology
Show more

Adagene Office Locations

Adagene has offices in Suzhou, San Diego and San Francisco
Suzhou, CN (HQ)
4f, building c14, no, 218 Xinghu St, Wuzhong Qu
San Diego, CA, US
10179 Huennekens St
San Francisco, CA, US
315 Montgomery St, San Francisco
Show all (3)

Adagene Financials and Metrics

Adagene Revenue

Adagene's revenue was reported to be $480 k in FY, 2019 which is a 68.2% decrease from the previous period.
USD

Revenue (FY, 2019)

480.0k

Revenue growth (FY, 2018 - FY, 2019), %

(68.2%)

Net income (FY, 2019)

(16.4m)

EBIT (FY, 2019)

(19.2m)

Market capitalization (8-Sept-2021)

742.0m

Closing stock price (8-Sept-2021)

17.0

Cash (30-Sept-2020)

82.9m

EV

665.4m
Adagene's current market capitalization is $742 m.
USDFY, 2018FY, 2019

Revenue

1.5m480.0k

Revenue growth, %

(68%)

General and administrative expense

2.8m3.4m

R&D expense

16.1m16.2m
Annual
USDFY, 2018FY, 2019

Cash

16.1m92.5m

Accounts Receivable

480.0k

Prepaid Expenses

295.5k211.4k

Current Assets

51.8m103.9m
Quarterly
USDQ3, 2020

Cash

82.9m

Prepaid Expenses

1.4m

Current Assets

86.6m

PP&E

1.8m
Annual
USDFY, 2018FY, 2019

Net Income

(15.3m)(16.4m)

Depreciation and Amortization

909.0k816.7k

Accounts Payable

389.1k153.7k

Cash From Operating Activities

(14.3m)(18.2m)
Quarterly
USDQ3, 2019Q3, 2020

Net Income

(11.8m)(29.6m)

Depreciation and Amortization

602.7k647.2k

Accounts Payable

(70.7k)494.6k

Cash From Operating Activities

(11.8m)(20.0m)
USDFY, 2018

Debt/Equity

-0.1 x

Financial Leverage

-1.3 x
Show all financial metrics

Adagene Operating Metrics

Q3, 2020

IND-Enabling Stage Products

6

Phase I Trials Products

4
Show all operating metrics

Adagene Acquisitions / Subsidiaries

Company NameDateDeal Size
ADAGENE AG
ADAGENE AUSTRALIA PTY LTD
Adagene (Hong Kong) Limited
Adagene Incorporated
ADAGENE PTE. LTD.
Adagene (Suzhou) Limited

Adagene Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

SecurityScorecard logo

Adagene Online and Social Media Presence

Embed Graph

Adagene News and Updates

Adagene Reports Financial Results for the Six Months Ended June 30, 2021 and Provides Corporate Updates

- Established three clinical collaborations with Merck to conduct global combination trials with pembrolizumab for three clinical-stage oncology candidates -

Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA® (pembrolizumab)

Collaboration to evaluate NEObody™ product candidate, ADG106, in combination with KEYTRUDA® for patients with advanced or metastatic solid and/or hematological malignancies Collaboration to evaluate NEObody™ product candidate, ADG106, in combination with KEYTRUDA® for patients with advanced or metas…

Adagene Announces Appointment of Interim Chief Medical Officer and New Members of Scientific and Strategic Advisory Board

- Global immuno-oncology experts bring decades of experience to advance company’s transformative research and development pipeline - - Global immuno-oncology experts bring decades of experience to advance company’s transformative research and development pipeline -

Adagene Announces Clinical Trial Collaboration With Merck to Advance Two Anti-CTLA-4 Monoclonal Antibody Programs (ADG116 and ADG126) in Combination Therapy with KEYTRUDA® (pembrolizumab)

Two global clinical studies to evaluate NEObody™ product candidate, ADG116, and SAFEbody™ product candidate, ADG126, in combination with KEYTRUDA® (pembrolizumab) for patients with advanced/metastatic solid tumors Two global clinical studies to evaluate NEObody™ product candidate, ADG116, and SAFEbo…

Adagene Announces Authorization of Share Repurchase Program up to US$20 Million

SAN FRANCISCO and SUZHOU, China, July 07, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced that its board of…

Adagene Announces Inclusion in FTSE Russell Indexes

SAN FRANCISCO and SUZHOU, China, June 16, 2021 (GLOBE NEWSWIRE) --  Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced that it will be …
Show more

Adagene Frequently Asked Questions

  • When was Adagene founded?

    Adagene was founded in 2012.

  • Who are Adagene key executives?

    Adagene's key executives are Man Kin Tam, Felix Du and Peter Luo.

  • How many employees does Adagene have?

    Adagene has 198 employees.

  • What is Adagene revenue?

    Latest Adagene annual revenue is $480 k.

  • What is Adagene revenue per employee?

    Latest Adagene revenue per employee is $2.4 k.

  • Who are Adagene competitors?

    Competitors of Adagene include Shanghai Henlius Biotech, Anavex and UT Health San Antonio MD Anderson Cancer Center.

  • Where is Adagene headquarters?

    Adagene headquarters is located at 4f, building c14, no, 218 Xinghu St, Wuzhong Qu, Suzhou.

  • Where are Adagene offices?

    Adagene has offices in Suzhou, San Diego and San Francisco.

  • How many offices does Adagene have?

    Adagene has 3 offices.